TABLE 1.
Xpla-heme derived from full-length XplA, P21 | XplA-heme-imidazole complex, P21212 | |
---|---|---|
Beamline | BM-14 (ESRF, Grenoble) | ID-23-EH2 (ESRF, Grenoble) |
Wavelength (Å) | 0.95350 Å | 0.87260 Å |
Resolution (Å) | 63.89-1.90 (1.95-1.90) | 124.03-1.49 (1.53-1.49) |
Space Group | P21 | P21212 |
Unit cell (Å) | a = 54.1, b = 123.0, c = 64.1 | a = 124.3, b = 64.7, c = 54.0 |
Molecules in asymmetric units | 2 | 1 |
Unique reflections | 57,099 (1926) | 68,213 (4663) |
Completeness (%) | 91.5 (41.9) | 99.6 (94.3) |
Rsym (%) | 0.057 (0.354) | 0.061 (0.191) |
Multiplicity | 1.8 (1.2) | 7.4 (7.1) |
〈I/σ(I)〉 | 10 (6) | 13 (10) |
Protein atoms | 6,153 | 3,093 |
Solvent waters | 485 | 709 |
Rcryst/Rfree | 0.167/0.214 | 0.147/0.176 |
r.m.s.d. 1–2 bonds (Å) | 0.025 | 0.012 |
r.m.s.d. 1–3 angles (°) | 1.917 | 1.411 |
Chiral centre (Å3) | 0.134 | 0.086 |
Planarity | 0.011 | 0.015 |
Average main-chain B (Å2) | 24 | 8 |
Average side-chain B (Å2) | 27 | 12 |
Average solvent B (Å2) | 32 | 29 |
Average ligand B (imidazole) | 19 |